55513-0160 Blincyto - CanMED: NDC

Product NDC:

55513-0160

Brand Name:

Blincyto

Generic Name:

Blinatumomab

Dosage Form Name:

Kit

Administration Route:

Intravenous

Substances:

Packages:

Code: 55513-0160-01

Description: 1 KIT in 1 PACKAGE (55513-160-01) * 3.088 mL in 1 VIAL (55513-150-01) * 10.6 mL in 1 VIAL (55513-155-01)

Effective Date: Dec. 18, 2014

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

CD3 (T cells) and CD19 (B cells)

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox